8 Nov 2022 13:24
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 7 November 2022, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Deferred Bonus Plan 2017 at a nil exercise price:
Name of PDMR | Number of shares subject to option | |
Stuart Quin | 87,409 | |
Richard Jones | 61,700 | |
Kevin Terrins | 38,181 | |
Sarah Burns | 38,181 | |
Marc O'Brien Caroline Byrne Rob Lavis | 46,275 21,389 24,722 | |
The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation, and set out more details of the transactions.
1. | Details of PDMR | |
(a) | Name | 1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis
|
2. | Reason for notification | |
(b) | Position / status | 1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director
|
Initial notification / amendment | Initial notification in each case | |
3. | Details of the Issuer | |
(a) | Name | Medica Group PLC |
(b) | LEI | 213800B8XE5FUSZF5Z16 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted | |
(a) | Description of the financial instrument | Ordinary shares of 0.2p each in the capital of the Company ("Shares") |
(b) | Nature of the transaction | Grant of options to acquire Shares pursuant to the Company's Deferred Bonus Plan 2017 |
(c) | Price(s) and volume | Option Price nil in each case 1. 87,409 2. 61,700 3. 38,181 4. 38,181 5. 46,275 6. 21,389 7. 24,722
|
(d) | Aggregated information | N/A |
(e) | Date of the transaction | 7 November 2022 |
(f) | Place of the transaction | Outside a trading venue |